Oct. 19—CARRINGTON, N.D. — Jam-packed schedules, sore muscles and hours of missed school have become the norm for Kacie Rexin and Kenadie Pazdernik this fall. No one is complaining though. Rexin and ...
Sep. 14—CARRINGTON, N.D. — When Kacie Rexin first started playing golf, other members of her family might have been able to beat her. "My family introduced me to golf when I was very young and I have ...
Michael Miller, an American businessman from North Carolina, was diagnosed with pancreatic cancer in May 2003. He underwent standard chemotherapy that started in June and continued until January this ...
Prediction of prognosis in hepatocellular carcinoma based on a gene signature from highly tumorigenic liver cancer cells. Background: To evaluate (1) the safety and antitumor activity of Rexin-G, and ...
Epeius Biotechnologies has announced the results of two related studies using Rexin-G, a tumor-targeted anti-cancer agent designed to seek-out and destroy metastatic cancers that have spread ...
Phase I study of vorinostat for patients with advanced solid tumors and hepatic dysfunction: An NCI Organ Dysfunction Working Group (ODWG) study (NCI #8057). Background: Rexin-G (R-G) and Reximmune-C ...
SAN MARINO, Calif., July 9 Epeius BiotechnologiesCorporation today announced that Rexin-G has been granted Orphan DrugDesignation by the U.S. Food and Drug Administration (FDA) for the treatmentof all ...
San Marino, Calif. - June 17, 2009 - Epeius Biotechnologies (www.epeiusbiotech.com) announced today that its lead product, Rexin-G, has been granted Fast Track designation by the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results